Clinical Trials · NCT06801015
Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions
- Phase
- Phase 4
- Recruitment status
- Active Not Recruiting
- Sponsor
- Mayo Clinic
- Enrollment
- 30
- Start date
- Oct 2025
- Locations
- 1 site, United States
- Primary endpoint
- Gastric emptying of solids T1/2 min, that is time for half meal to empty from stomach